Tianjin Chase Sun Pharmaceutical Co.,Ltd Sustainability Profile
Tianjin Chase Sun Pharmaceutical Co., Ltd., commonly referred to as Chase Sun, is a prominent player in the pharmaceutical industry, headquartered in Tianjin, China. Established in 1995, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including generic drugs and active pharmaceutical ingredients (APIs). With a strong operational presence across various regions in China and beyond, Chase Sun is recognised for its commitment to quality and innovation. The company’s core offerings, which include oncology and cardiovascular medications, stand out due to their rigorous research and development processes. Chase Sun has achieved notable market positioning, underscoring its reputation for excellence in the pharmaceutical sector. As a forward-thinking organisation, it continues to contribute to global health advancements while maintaining a focus on sustainable practices.
DitchCarbon Score
How does Tianjin Chase Sun Pharmaceutical Co.,Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tianjin Chase Sun Pharmaceutical Co.,Ltd's score of 22 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tianjin Chase Sun Pharmaceutical Co.,Ltd's reported carbon emissions
Tianjin Chase Sun Pharmaceutical Co., Ltd, headquartered in CN, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As there are no emissions data or reduction initiatives available, it is unclear how Tianjin Chase Sun Pharmaceutical aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the pharmaceutical sector, where companies are increasingly being urged to disclose their environmental impacts and set ambitious targets for emissions reductions. In summary, Tianjin Chase Sun Pharmaceutical Co., Ltd has not provided emissions data or climate commitments, indicating a potential area for improvement in transparency and sustainability practices within the industry.
How Carbon Intensive is Tianjin Chase Sun Pharmaceutical Co.,Ltd's Industry?
How Carbon Intensive is Tianjin Chase Sun Pharmaceutical Co.,Ltd's Location?
Tianjin Chase Sun Pharmaceutical Co.,Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tianjin Chase Sun Pharmaceutical Co.,Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
